Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Cash Flow from Operations

Apellis Pharmaceuticals Inc Cash Flow from Operations Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Cash Flow from Operations from 2017 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Apellis Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-44m a 48.43% decrease of -22m year over year
  • Apellis Pharmaceuticals Inc Cash Flow from Operations for the last 12 months ending December 12, 2018 was $-131m a 53.44% decrease of -70m year over year
  • Apellis Pharmaceuticals Inc Annual Cash Flow from Operations for 2018 was $-131m a 64.50% decrease of -85m from 2017
  • Apellis Pharmaceuticals Inc Annual Cash Flow from Operations for 2017 was $-47m a 44.19% decrease of -21m from 2016
  • Apellis Pharmaceuticals Inc Annual Cash Flow from Operations for 2016 was $-26m a 27.49% decrease of -7m from 2015
Other Cash Flow Metrics:
  • Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-39m a 62.21% decrease of -24m year over year
View Chart On Koyfin

Quarterly APLS Cash Flow from Operations Data

12/2018$-44m
09/2018$-33m
06/2018$-31m
03/2018$-23m
12/2017$-16m
09/2017$-11m
06/2017$-11m
03/2017$-8m

Annual APLS Cash Flow from Operations Data

2018$-131m
2017$-47m
2016$-26m
2015$-19m